Global Public Health Partnering Deal Trends, Players and Financials Analysis 2010-2020 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Public Health Partnering 2010-2020: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering.

Global Public Health Partnering 2010 to 2020 provides the full collection of Public Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline values, upfront payments, milestones

Read More

Focus on Deal Trends, Players and Financials Since 2010

Dublin, Sept. 21, 2020 (GLOBE NEWSWIRE) — The “Global Public Health Partnering 2010-2020: Deal Trends, Players and Financials” report has been added to ResearchAndMarkets.com’s offering.

Global Public Health Partnering 2010 to 2020 provides the full collection of Public Health disease deals signed between the world’s pharmaceutical and biotechnology companies since 2010.

Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor’s product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.

The report takes readers through the comprehensive Public Health disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Public Health deals.

The report presents financial deal terms values for Public Health deals, where available listing by overall headline

Read More